Christine Wittmann
Papers
2
Total Citations
57
H-Index
2
About
Christine Wittmann is a researcher at the forefront of drug discovery, specializing in high-throughput, whole-animal screening methods using zebrafish larvae. Her major contribution lies in developing an automated, high-content inflammation assay that harnesses the unique advantages of zebrafish—their small size, ease of manipulation, and ability to absorb compounds directly from bathing water. This innovative approach enables rapid, in vivo assessment of anti-inflammatory compounds, bridging the gap between in vitro assays and mammalian models. Her flagship work, "Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish" (2012), has garnered over 57 citations, reflecting its significant impact on the field. By streamlining the drug discovery pipeline, Wittmann’s research accelerates the identification of promising therapeutic candidates, offering a cost-effective and ethically favorable alternative to traditional methods. Her work is a cornerstone for researchers seeking to integrate zebrafish models into early-stage pharmacological studies, demonstrating how automation and whole-organism biology can revolutionize the search for new medicines.
Research Focus
Key Achievements
Top Papers
- 1
- 2